bioRxiv ScienceSearch

bioRxiv · 10.1101/543926

Intrinsic structure of model-derived metrics for in silico proarrhytmic riskassessment identified by global sensitivity analysis

Abstract

Multiscale computational models of heart are being extensively investigated for improved assessment of drug-induced Torsades de Pointes (TdP) risk, a fatal side effect of many drugs. Model-derived metrics (features) such as action potential duration, net charge carried by ionic currents (qNet) and others have been proposed in the past as potential candidates for classifying TdP risk. However, the criteria for selection of new risk metrics are still poorly justified, and they are often trained/tested only on small datasets. Moreover, classifiers built on derived features have thus far not consistently provided increased prediction accuracies compared to classifiers based on in vitro measurements of drug effects on ion channels (direct features). In this paper, we analyze a large population of virtual drugs to examine systematically the sensitivity of several model-derived features. The influence of different ion channels in regulation of the model-derived features is identified using global sensitivity analysis (GSA). Specifically, the analysis points to key differences in the input parameters that affect several model-derived features and the generation of early afterdepolarizations (EAD), thus opposing the idea that these features and sensitivity to EAD might be strongly correlated. We also demonstrate that previously proposed model-derived features could be well fitted by a linear combination of direct features. This well explains the observed comparable performances of classifiers built on direct features and model-derived features. Combining GSA and simple probability analysis, we also show that the odds of any linear metric constructed from direct features to perform as well as qNet is very low. Nevertheless, despite high predictive power of qNet to separate drugs into correct categories of TdP risk, the GSA results suggest that the actual mechanistic interpretation for qNets improved performance deserves further investigation. In conclusion, analyses like ours can provide more robust feature selection/construction. Improved experimental designs with increased focus on the critical model parameters indicated by GSA can potentially reduce the uncertainties of key model components and result in increased confidence of TdP risk predicted by in silico models. Author SummaryBiophysical models often have extremely involved intrinsic structure. In the majority of research, either complex methods of non-linear dynamics and empirical analysis are employed to explore the underlying structure of cell processes such as transmembrane ionic currents. Global sensitivity analysis (GSA) could be considered as a brute force alternative to study the model relationships between physical processes, discovering the mechanisms responsible for phenomena of interest. As we demonstrated here, GSA application could be extended to explore the structure of features derived from outputs of biophysical models and used in statistical models to build regressions or classifiers. In particular, GSA seems to be valuable to formalize the methods of feature selection/construction that are used for classification of drugs with respect to their cardiotoxicity.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Parikh, J., Di Achille, P., Kozloski, J., Gurev, V.. 2019-02-07. Intrinsic structure of model-derived metrics for in silico proarrhytmic riskassessment identified by global sensitivity analysis. https://doi.org/10.1101/543926

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Lipid-ASO therapeutics exhibit differential tissue targeted delivery upon systemic or local CNS administration

Antisense oligonucleotides (ASOs) are a powerful therapeutic modality, but their full potential is hindered by pharmacokinetic properties that affect tissue and cellular delivery. Lipid conjugation is increasingly used to modulate ASO's biodistribution and promote extrahepatic activity, yet lipid dependent effects on in vivo functional delivery, particularly in the central nervous system (CNS), remain less explored. Here, we performed a side by side in vivo comparison of cholesterol, palmitic acid (C16:0), docosanoic acid (C22:0), and eicosapentaenoic acid (C20:5) conjugated to a fully phosphorothioated 3 10 3 LNA gapmer ASO targeting the Malat1 long non coding RNA. Lipid-ASO conjugates were administered systemically or locally in the brain of mice and evaluated for tissue level and cellular level distribution by imaging, qPCR and single-cell RNA sequencing, simultaneously annotating cell origin and global transcriptional changes within the cell. Following systemic administration in mice, lipid conjugation improved overall multi organ efficacy compared to unconjugated ASO, but with pronounced tissue specific differences. Single cell sequencing of liver and heart transcriptomes revealed lipid dependent cellular uptake patterns and transcriptional responses distinct from administration of unconjugated ASO. After intracerebroventricular administration, selected fatty acid conjugates enhanced silencing in deep brain regions such as the striatum, whereas cholesterol conjugation impaired functional delivery despite increased CNS retention. Light-sheet microscopy showed restricted parenchymal penetration of cholesterol ASOs compared with broader but heterogeneous distribution of palmitic acid conjugate. Together, these findings demonstrate that lipid identity critically determines ASO efficacy, productive cellular uptake, and regional CNS engagement, emphasizing the need for context specific lipid design in ASO therapeutic development.

pharmacology and toxicology

Novel Dissymmetric Ionizable Lipid-Assembled Lipid Nanoparticles for Delivery of Ferroptosis-Related siRNA in Diabetic Treatment

Small interfering RNA (siRNA) enables precise post-transcriptional gene silencing for refractory diseases, yet its clinical translation remains limited by the lack of safe and efficient delivery vectors. Inspired by the dissymmetric alkyl chain architecture of natural membrane phospholipids, we designed and synthesized 34 novel ionizable lipids with dissymmetric hydrophobic tails and formulated them into lipid nanoparticles (LNPs). Through systematic physicochemical and biological assessments, we established clear structure-activity relationships and identified two lead LNPs (O14-LNP, H18a-LNP) with superior endosomal escape capacity, enhanced in vivo gene silencing potency, and favorable biosafety relative to the clinical benchmark MC3-LNP. In both streptozotocin-induced and spontaneous db/db type 2 diabetes (T2D) mouse models, lead LNPs delivering ferroptosis-related siRNAs effectively ameliorated glucose and lipid metabolic disorders, restored islet function, and alleviated hepatic steatosis. This study not only lays a theoretical foundation for the rational design of novel ionizable lipids, but also validates the therapeutic potential of siRNA therapy targeting ferroptosis, providing a versatile delivery platform and targeted therapeutic strategy for the treatment of T2D.

pharmacology and toxicology

Vapor inhalation of cannabidiol (CBD) in rats

Cannabidiol (CBD) is increasingly available in e-cigarette liquids and other products. CBD use has been promoted for numerous purported benefits which have not been rigorously assessed in preclinical studies. The objective of this study was to further validate an inhalation model to assess CBD effects in the rat. The primary goal was to determine plasma CBD levels after vapor inhalation and compare that with the levels observed after injection. Secondary goals were to determine if hypothermia is produced in male Sprague-Dawley rats and if CBD affects nociception measured by the warm water tail-withdrawal assay. Blood samples were collected from rats exposed for 30 minutes to vapor generated by an e-cigarette device using CBD (100, 400 mg/mL in the propylene glycol vehicle). Separate experiments assessed the body temperature response to CBD in combination with nicotine (30 mg/mL) and the anti-nociceptive response to CBD. Vapor inhalation of CBD produced concentration-related plasma CBD levels in male and female Wistar rats that were within the range of levels produced by 10 or 30 mg/kg, CBD, i.p.. Dose-related hypothermia was produced by CBD in male Sprague-Dawley rats and this was partially attenuated by 5-HT1a receptor blockade. Nicotine (30 mg/mL) inhalation enhanced the effect of CBD. CBD inhalation had no effect on anti-nociception alone or in combination with {Delta}9-tetrahydrocannabinol inhalation. The vapor-inhalation approach is a suitable pre-clinical model for the investigation of the effects of inhaled CBD. This route of administration produces hypothermia in rats, while i.p. injection does not at comparable plasma CBD levels.

pharmacology and toxicology